Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Invivyd Inc
IVVD
Healthcare
Biotechnology
Invivyd, Inc. is a commercial-stage company, which is engaged in delivering antibody-based therapies. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral...
threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2 (COVID-19). Its PEMGARDA is the Company’s first mAb in a planned series of innovative mAb candidates designed to keep pace with SARS-CoV-2 viral evolution. Its VYD2311 is optimized for neutralization potency against recent SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IVVD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(68)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 23, 2022 11:15pm
ADGI APPOINT DAVID HERING AS INTERIM CEO
EOM
(68)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 22, 2022 9:19am
ADGI:TO ANALYZE DATA FROM TRIALS GLOBALLY/RESULTS END MARCH
BRIEF-Adagio Therapeutics Outlines Strategic Initiatives For Co's ADG20 Program Published by Reuters 2022 Feb 22, 13:46 Feb 22 (Reuters) - Adagio Therapeutics Inc
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(68)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 19, 2022 9:19am
ADGI CEO RESIGNS/REPLACED BY COO INTERMILY
Adagio Therapeutics Announces CEO Succession Plan https://finance.yahoo.com/news/adagio-therapeutics-announces-ceo-succession-003300169.html Fri, February 18, 2022, 7:33 PM Adagio
...more
(33)
•••
petrojell
X
View Profile
View Bullboard History
Post by
petrojell
on Feb 09, 2022 2:10pm
Fekb 09, 2022
Nice price run up and volume. What will 4pm and rest of week say. What are we waiting to say ADGI...
(4)
•••
AviseAnalytics
X
View Profile
View Bullboard History
Post by
AviseAnalytics
on Feb 08, 2022 8:59am
5 BIOTECH STOCKS WITH MAJOR UPCOMING CATALYSTS
$ADGI $CYTK $PHAT $AGIO $ICPT Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these companies bring new and highly differentiated
...more
(68)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Feb 07, 2022 12:58pm
any thoughts whats driving adgi tdy?
thx if you're reading this, would welcome all opinions
(68)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jan 13, 2022 9:39am
ADGI COVID-19 ANTIBODY NEUTRALIZING ACTIVITY.......
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies Vandana Singh , Benzinga Staff Writer FOLLOW January 13, 2022 7:08am
...more
(68)
•••
Humanist
X
View Profile
View Bullboard History
Post by
Humanist
on Jan 10, 2022 10:12am
ADGI TO PRESENT AT JP MORGAN ANNUAL HEALTH CONF JAN 13/7:30
this is an impt conference, i assume if they didn't have anything good to shae and excite other health companies, or if they're not looking for collaboration swith something good to
...more
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Dec 20, 2021 4:46pm
ADGI - DROP IN PRICE WHATS NEXT
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Dec 18, 2021 12:30am
ADGI - Friday Rundown, Monday Expectations
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Dec 17, 2021 4:18am
ADGI - Price Prediction
(30)
•••
MushLove
X
View Profile
View Bullboard History
Comment by
MushLove
on Dec 16, 2021 6:42pm
RE:ADGI - Home Run Play
Crazy price swings.
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Dec 16, 2021 3:03pm
ADGI - Home Run Play
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Dec 01, 2021 10:03pm
ADGI - Wednesday Rundown, Thursday Expectations
(15)
•••
HDavis
X
View Profile
View Bullboard History
Post by
HDavis
on Nov 30, 2021 3:46pm
ADGI - Home Run Play
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden